Rectal adenocarcinoma: 154 cases prognosis study
##plugins.themes.academic_pro.article.main##
Abstract
Background: during this century, therapeutic management of rectal cancer has known a lot of advances. Survival is still depending on factors related to the patient, the tumor or the surgeon.
Aim: The aim of our study is to report survival and prognosis factors of our patients managed for a rectal cancer.
Methods: We report an descreptive retrospective study about 154 patients. SPSS 19.0 version was used for the statistical analysis. Desriptive study was done using means, and pourcentage. Survival was analysed using Kaplan meier curve. In univariate analysis, we calculated the odd ratio in order to evaluate risk factors. Multivariate analysis used Cox model. Significancy was 0.05.
Results: Global survival was 52.4% at 3 years and 42.4% at 5 years. Free reccurence survival was 76% at 3 years and 69.15% at 5 years.
In univariate analysis, factors significantly influencing survival were age>70 years, CAE level, tumor perforation, TNM, tumor differentiation, peroperative blood transfusion, and reccurency. In multivriate analysis, only age > 70 years, T and local reccurency were independants factors influencing survival.
Conclusion: A better knowledge of prognosis factors ead to a better management of this cancer with more adjuvant treatment indications and closer monitoring.
Keywords:
rectal cancer-survival, survival, prognosis, predictif factor##plugins.themes.academic_pro.article.details##
References
- Akhavan A, Binesh F, Soltani A. Survival of rectal cancer in Yazd, Iran. Asian Pac J Cancer Prev. 2014;15(12):4857-60.
- Burton S, Norman AR, Brown G, M Abulafi A, Swift RI. Predictive poor prognostic factors in colonic carcinoma. Surg Oncol 2006;15(2):71-8
- Peng J, Xu Y, Guan Z Zhu J, Wang M, Cai G et al. Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Ann Surg Oncol 2008;15(11):3118-23.
- Liang J, Wei Y, Zhao C, Hong Cl. Metastatic lymph node ratio and outcome of surgical patients with stage III colorectal cancer. Nan Fang Yi Ke Da Xue Xue Bao.2012 ;32(11) :1663-6.
- Attaallah W, Gunal O, Manukyan M, Ozden G, Yegen C. Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Rectal Cancer. Ann Coloproctol 2013;29(3):100-105.
- Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, Hsieh JS et al. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer 2009;9:288-96.
- Nazato DM, Matos LL, Weisberg DR, Souza Jr, Martins LC, Weisberg J. Prognostic value of carcinoembryonic antigen distribution in tumor tissue of colorectal carcinoma. Arg Gastroenterol 2009;46(1):26-31.
- Bozkurt O, INANC M, Turkmen E, Karaca H, Berk V, DURAN AO et al. Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer. Asian pac j cancer prev 2014;15(21):9277-81.
- Larsen SG, Wiig JN, Dueland S, Giercksky KE. Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer. Eur J Surg Oncol 2008;34 (4]:410-7.
- Fernando Cabanillas, Viviana Freire, Mariely Nieves-Plaza, Gerardo Quevedo, Ignacio A. Echenique. Rectal Adenocarcinoma: Proposal for a Model Based on Pretreatment Prognostic Factors P R Health Sci J 2012 ; 31(2): 52-58.
- Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86(3):556-565.
- Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. J Clin Oncol. 2006;24(22):3527-34.
- Porter GA, O'Keefe GE, Yakimets WW. Inadvertent perforation of the rectum during abdominoperineal resection. Am J Surg 1996;172(4):324-7.